Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Study data from E. Lorenz and co-authors update knowledge of cervical cancer
April 2nd, 2009
Researchers in Trondheim, Norway conducted a study "To study the treatment of patients with cervical carcinoma with regard to side effects and survival. A retrospective analysis of 107 patients with cervical carcinoma treated by radiotherapy with curative intent between January 1, 1987 and December 31, 2001." "Median follow-up: 139 months for surviving patients and 23 months for deceased patients. Five-year overall and disease-specific survival for all stages was 36% and 45%, respectively. Corresponding figures for each stage were, Stage I: 54% and 80%, Stage II: 41% and 56% Stage III: 33% and 36% and Stage IV: < 1%. Five-year actuarial incidence of late reactions,...
Source: Women's Health Weekly (2009-04-02)
|
